Naresh Varma Seelama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Naresh Varma Seelama has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Deepti Kolli
Department of Chemistry, Koneru Lakshmaiah Education Foundation
1 shared publication - Duggirala S. Ramakrishna
Department of Chemistry, Veer Surendra Sai University of Technology, Burla 768018, Sambalpur, Odisha, India
1 shared publication - P. Venkatanarayana
Department of Engineering Chemistry, College of Engineering, Koneru Lakshmaiah Education Foundation, Guntur, Andhra Pradesh, India
1 shared publication
Latest Publications
- 6 December 2022
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 42 (6) , 427-435
Synthesis of molnupiravir (MK-4482, EIDD-2801): a promising oral drug for the treatment of COVID-19 starting from cytidine
The present work describes the synthesis of molnupiravir by employing commercially available inexpensive materials in two steps with an overall yield of 85.7%. The synthetic methodology starts with an eco-friendly starting material, that is, cytidine and establishes an alternative way to avoid costly enzyme mediated reactions. This synthetic strategy involves a selective acylation of cytidine as the first key step followed by the second step, that is, hydroxamination reaction. The major advantage of this protocol is that it is completely free of protection and deprotection reactions. Chemoselective acylation of cytidine's primary alcohol was achieved using isobutyryl chloride, Et3N, and DMF solvent (89.3% yield). The aqueous phase transformation was achieved for the hydroxamination reaction with a 96% yield.
- 6 December 2022
- Published by Taylor & Francis in Nucleosides, Nucleotides & Nucleic Acids
- Vol. 42 (6) , 427-435
Synthesis of molnupiravir (MK-4482, EIDD-2801): a promising oral drug for the treatment of COVID-19 starting from cytidine
The present work describes the synthesis of molnupiravir by employing commercially available inexpensive materials in two steps with an overall yield of 85.7%. The synthetic methodology starts with an eco-friendly starting material, that is, cytidine and establishes an alternative way to avoid costly enzyme mediated reactions. This synthetic strategy involves a selective acylation of cytidine as the first key step followed by the second step, that is, hydroxamination reaction. The major advantage of this protocol is that it is completely free of protection and deprotection reactions. Chemoselective acylation of cytidine's primary alcohol was achieved using isobutyryl chloride, Et3N, and DMF solvent (89.3% yield). The aqueous phase transformation was achieved for the hydroxamination reaction with a 96% yield.